EXPRESSION OF HUMAN B CELL-ASSOCIATED ANTIGENS ON LEUKEMIAS AND LYMPHOMAS - A MODEL OF HUMAN B-CELL DIFFERENTIATION
EXPRESSION OF HUMAN B CELL-ASSOCIATED ANTIGENS ON LEUKEMIAS AND LYMPHOMAS - A MODEL OF HUMAN B-CELL DIFFERENTIATION
复制标题
DOI:
10.1182/blood.v63.6.1424.1424
复制
发表时间:
1984-01-01
期刊:
影响因子:
20.3
通讯作者:
NADLER, LM
中科院分区:
文献类型:
--
作者:
ANDERSON, KC;BATES, MP;NADLER, LM
A series of monoclonal antibodies that define B cell restricted and associated antigens was utilized in an attempt to characterize tumors of B lineage and to relate these tumors to B cell differentiative stages. Antigens that were previously shown to be B cell restricted on normal B lymphocytes were similarly expressed only on B cell malignancies. Antigens that were B cell associated were also found on tumors of other lineages. On the basis of cell surface phenotypes, tumors of B cell origin were divided into 3 major subgroups, which corresponded to the level of differentiation of the malignant tumor cell: pre-B cell stage (non-T acute lymphoblastic leukemia and chronic myelocytic leukemia in lymphoid blast crisis); the mid-B cell stage (chronic lymphocytic leukemia, poorly differentiated lymphomas); and secretory B cell (large stage cell lymphomas and plasma cell tumors). The malignant B cell was related to its normal cellular counterpart on the basis of cells urface expression of this panel B cell-restricted and B cell-associated antigens.